Co-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease

Raffaele Antonelli Incalzi, Leonello Fuso, M. De Rosa, +4

European Respiratory Journal

Cardiovascular DiseaseCo-morbidity ContributesAdvanced Lung DiseasePrognosisClinical Epidemiology +11

Wireless Sensor Networks for Home Health Care

Chris R. Baker, Kenneth Armijo, Simon Belka, +19

NursingSensor NetworksWireless TelemedicineMedical MonitoringHome Health Monitoring +13

Italian cancer figures, report 2012: Cancer in children and adolescents.

Paola Pisani, Carlotta Buzzoni, Emanuele Crocetti, +366

BOA (University of Milano-Bicocca)

The relative burden of diabetes complications on healthcare costs: The population-based CINECA-SID ARNO Diabetes Observatory

Eva Pagano, M. De Rosa, Elisa Rossi, +6

Nutrition Metabolism and Cardiovascular Diseases

Diabetes ManagementRelative BurdenHealth PolicyHealth EconomicsDiabetes +8

The Direct Economic Cost of Pharmacologically-Treated Diabetes in Italy-2006. The ARNO Observatory

Giulio Marchesini, G Forlani, Elisa Rossi, +2

Nutrition Metabolism and Cardiovascular Diseases

Diabetes ManagementHealth PolicyHealth EconomicsDirect Economic CostDiabetes +6

Three years of experience: the Italian registry and safety data update

Gianluigi Mancardi, G. Tedeschi, Maria Pia Amato, +21

Neurological Sciences

EpidemiologyEngineeringSafety ManagementHealth PolicyRisk Management +9

Under-treatment of migrants with diabetes in a universalistic health care system: The ARNO Observatory

Giulio Marchesini, D. Bernardi, Roberto Miccoli, +5

Nutrition Metabolism and Cardiovascular Diseases

Human MigrationDiabetes ManagementHealth PolicyDiabetesArno Observatory +4

Post-thyroidectomy dysphonia in patients with bilateral resection of the superior laryngeal nerve: a comparative spectrographic study.

Giampiero Neri, F Castiello, Francesca Vitullo, +3

PubMed

Post-thyroidectomy DysphoniaBilateral ResectionSelf-evaluation Voice QuestionnaireMedicineThyroid Disease +12

The pharmacovigilance program on natalizumab in Italy: 2 years of experience

G. Tedeschi, Maria Pia Amato, Roberto D’Alessandro, +21

Neurological Sciences

Drug SafetyMedicineDrug DiscoveryPharmacovigilancePharmacotherapy +5

Incidence, prevalence, costs and quality of care of type 1 diabetes in Italy, age 0–29 years: The population-based CINECA-SID ARNO Observatory, 2002–2012

Graziella Bruno, Eva Pagano, Elisa Rossi, +6

Nutrition Metabolism and Cardiovascular Diseases

Type 1Diabetes ManagementDiabetes EpidemiologyHealth EconomicsHealth Policy +9